Britta Olenik

USPTO Granted Patents = 23 (Patent Applications = 22)

CIPO Patents = 2 (Patent Applications = 15)

EPO Patents = 13 (Patent Applications = 38)

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 14(Granted Patents)

Company Filing History:

Bayer Pharma Aktiengesellschaft

patents

4 out of 12,157

Bayer Aktiengesellschaft

Bayer Intellectual Property Gmbh

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

23 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12202805 - Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound (2025-01-21),

2. 12138256 - Treatment of cardiopulmonary disorders (2024-11-12),

3. 11618735 - Crystal forms of the monosodium salt of foramsulfuron (2023-04-04),

4. 11344519 - Orally administrable modified-release pharmaceutical dosage form (2022-05-31),

5. 11332435 - Method for producing (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4- chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclo-propylpropanoic acid and the crystalline form thereof for use as a pharmaceutical ingredient (2022-05-17),

6. 10905667 - Orally administrable modified-release pharmaceutical dosage form (2021-02-02),

7. 10676443 - Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile (2020-06-09),

8. 10479765 - Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents (2019-11-19),

9. 10472331 - Crystal forms of the monosodium salt of foramsulfuron (2019-11-12),

10. 10336716 - Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide (2019-07-02),

11. 10316001 - Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile (2019-06-11),

12. 10189788 - Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents (2019-01-29),

13. 10117864 - Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof (2018-11-06),

14. 9926305 - Salts (2018-03-27),

15. 9783534 - Crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1, 3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulphonate (2017-10-10),

Title: Inventor Britta Olenik: Pioneering Innovations in Bottrop

Introduction: Britta Olenik is a visionary inventor hailing from Bottrop, Germany, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Britta Olenik holds several patents in the areas of renewable energy technologies, sustainable materials, and smart devices, showcasing her commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Britta Olenik has worked with leading research institutions and tech companies to bring her innovative ideas to life. Her passion for pushing the boundaries of technology has led to numerous successful inventions that have made a significant impact on various industries.

Collaborations: Throughout her career, Britta Olenik has collaborated with top engineers, scientists, and designers to develop cutting-edge solutions to complex challenges. Her collaborative spirit and interdisciplinary approach have been key to her success as an inventor.

Conclusion: Britta Olenik's relentless pursuit of innovation and her dedication to creating a better world through technology make her a true pioneer in the field of inventions. Her work continues to inspire the next generation of inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.